E2

AI is moving inside the medical record. Privacy is only part of the risk

The mRNA Cancer Vaccine Story Just Got Less Comfortable

Thailand Beat Rubella.

Outbreaks Ignore Borders.

Mpox Finally Gets A Stockpile

AMR Has An Equity Problem

Canada Moves. Alzheimer’s Patients Still Wait.

Beyond GLP-1s: Lilly is spending billions on a more targeted future in neuroscience

FDA Is Asking the Right AI Question: Who Watches the Model After Approval?
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
